Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of β-naltrexamine
- Author
- DERRICK, I1 ; LEWIS, J. W1 ; MOYNIHAN, H. A1 ; BROADBEAR, J; WOODS, J. H
[1] School of Chemistry, University of Bristol, Bristol BS8 1TS, United Kingdom - Source
Journal of pharmacy and pharmacology. 1996, Vol 48, Num 2, pp 192-196 ; ref : 19 ref
- CODEN
- JPPMAB
- ISSN
- 0022-3573
- Scientific domain
- Pharmacology drugs
- Publisher
- Pharmaceutical Press, Wallingford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Animal Antagoniste Appareil digestif Appareil urogénital Canal déférent Cobaye Fixation biologique Iléon In vitro In vivo Intestin Irréversible Nociception Récepteur opiacé Souris BU 42 BU 59 BU 60 Naltrexamine dérivé Mammalia Rodentia Vertebrata
- Keyword (en)
- Animal Antagonist Digestive system Urogenital system Vas deferens Guinea pig Biological fixation Ileum In vitro In vivo Gut Irreversible Nociception Opiate receptor Mouse Mammalia Rodentia Vertebrata
- Keyword (es)
- Animal Antagonista Aparato digestivo Aparato urogenital Canal deferente Cobayo Fijación biológica Ileon In vitro In vivo Intestino Irreversible Nocicepción Receptor opiáceo Ratón Mammalia Rodentia Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B09 Neurotransmitters. Neurotransmission. Receptors / 002B02B09F Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3033014
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.2042-7158.1996.tb07121.x 
https://dx.doi.org/10.1111/j.2042-7158.1996.tb07121.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1996.tb07121.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of pharmacy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. pharm. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"196\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3573\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DERRICK\";s:10:\"\u0000*\u0000aufirst\";s:1:\"I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:11:\"LEWIS, J. W\";i:1;s:14:\"MOYNIHAN, H. A\";i:2;s:12:\"BROADBEAR, J\";i:3;s:11:\"WOODS, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPPMAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:8:\"\u0000*\u0000place\";s:11:\"Wallingford\";s:6:\"\u0000*\u0000pub\";s:20:\"Pharmaceutical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1996.tb07121.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of pharmacy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. pharm. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"196\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3573\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DERRICK\";s:10:\"\u0000*\u0000aufirst\";s:1:\"I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:11:\"LEWIS, J. W\";i:1;s:14:\"MOYNIHAN, H. A\";i:2;s:12:\"BROADBEAR, J\";i:3;s:11:\"WOODS, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPPMAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:8:\"\u0000*\u0000place\";s:11:\"Wallingford\";s:6:\"\u0000*\u0000pub\";s:20:\"Pharmaceutical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1996.tb07121.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1996.tb07121.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of pharmacy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. pharm. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"196\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3573\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DERRICK\";s:10:\"\u0000*\u0000aufirst\";s:1:\"I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:11:\"LEWIS, J. W\";i:1;s:14:\"MOYNIHAN, H. A\";i:2;s:12:\"BROADBEAR, J\";i:3;s:11:\"WOODS, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPPMAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:8:\"\u0000*\u0000place\";s:11:\"Wallingford\";s:6:\"\u0000*\u0000pub\";s:20:\"Pharmaceutical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1996.tb07121.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of pharmacy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. pharm. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"196\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3573\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DERRICK\";s:10:\"\u0000*\u0000aufirst\";s:1:\"I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:11:\"LEWIS, J. W\";i:1;s:14:\"MOYNIHAN, H. A\";i:2;s:12:\"BROADBEAR, J\";i:3;s:11:\"WOODS, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPPMAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:8:\"\u0000*\u0000place\";s:11:\"Wallingford\";s:6:\"\u0000*\u0000pub\";s:20:\"Pharmaceutical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.2042-7158.1996.tb07121.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of pharmacy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. pharm. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"192\";s:8:\"\u0000*\u0000epage\";s:3:\"196\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3573\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DERRICK\";s:10:\"\u0000*\u0000aufirst\";s:1:\"I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:11:\"LEWIS, J. W\";i:1;s:14:\"MOYNIHAN, H. A\";i:2;s:12:\"BROADBEAR, J\";i:3;s:11:\"WOODS, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPPMAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of \u03b2-naltrexamine\";s:8:\"\u0000*\u0000place\";s:11:\"Wallingford\";s:6:\"\u0000*\u0000pub\";s:20:\"Pharmaceutical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
